Nuvation Bio Inc. (NYSE:NUVB) Receives $7.83 Average Target Price from Analysts
Nuvation Bio Inc. (NYSE:NUVB – Get Free Report) has received an average rating of “Buy” from the six brokerages that are covering the stock, Marketbeat Ratings reports. Five investment analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 12 month price objective […]
Nuvation Bio Inc. (NYSE:NUVB – Get Free Report) has received an average rating of “Buy” from the six brokerages that are covering the stock, Marketbeat Ratings reports. Five investment analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 12 month price objective […]
